

<!-- DFS ActiveDisclosure(SM) XBRL Schema Document - http://www.dfsco.com/financial-services/ -->
<!-- Creation Date      : 2019-03-26T17:27:28.7455395+00:00 -->
<!-- Version            : 3.3.6989.14284 -->
<!-- Package ID         : f9c653f968ca43efb3ac33a4d47fff0f -->
<!-- Copyright (c) 2019 Donnelley Financial, LLC. All Rights Reserved. -->
<schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:akba="http://akebia.com/20181231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://akebia.com/20181231" xmlns="http://www.w3.org/2001/XMLSchema">
  <import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <import schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2018-01-31" />
  <import schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" namespace="http://fasb.org/us-gaap/2018-01-31" />
  <import schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" namespace="http://fasb.org/srt/2018-01-31" />
  <import schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" namespace="http://fasb.org/us-types/2018-01-31" />
  <import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <import schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd" namespace="http://fasb.org/srt-types/2018-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" namespace="http://xbrl.sec.gov/country/2017-01-31" />
  <import schemaLocation="https://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2017-01-31" />
  <import schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2018-01-31" />
  <import schemaLocation="https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31" />
  <import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <import schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
  <import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <annotation>
    <appinfo>
      <link:roleType id="TemplateLink" roleURI="http://akebia.com/20181231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="akba-20181231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="akba-20181231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="akba-20181231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="akba-20181231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100040 - Statement - Consolidated Statements of Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>100050 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureNatureOfOrganizationAndOperations" id="Role_DisclosureNatureOfOrganizationAndOperations">
        <link:definition>100070 - Disclosure - Nature of Organization and Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureProductRevenueNet" id="Role_DisclosureProductRevenueNet">
        <link:definition>100090 - Disclosure - Product Revenue, Net</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreements" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreements">
        <link:definition>100100 - Disclosure - License, Collaboration and Other Significant Agreements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombination" id="Role_DisclosureBusinessCombination">
        <link:definition>100110 - Disclosure - Business Combination</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAvailableForSaleSecurities" id="Role_DisclosureAvailableForSaleSecurities">
        <link:definition>100120 - Disclosure - Available for Sale Securities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureFairValueOfFinancialInstruments" id="Role_DisclosureFairValueOfFinancialInstruments">
        <link:definition>100130 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureInventory" id="Role_DisclosureInventory">
        <link:definition>100140 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIntangibleAssetsAndGoodwill" id="Role_DisclosureIntangibleAssetsAndGoodwill">
        <link:definition>100150 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAccruedExpenses" id="Role_DisclosureAccruedExpenses">
        <link:definition>100160 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureDebt" id="Role_DisclosureDebt">
        <link:definition>100170 - Disclosure - Debt</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureWarrant" id="Role_DisclosureWarrant">
        <link:definition>100180 - Disclosure - Warrant</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>100190 - Disclosure - Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100200 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureEmployeeRetirementPlan" id="Role_DisclosureEmployeeRetirementPlan">
        <link:definition>100210 - Disclosure - Employee Retirement Plan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100220 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100230 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureQuarterlyResultsUnaudited" id="Role_DisclosureQuarterlyResultsUnaudited">
        <link:definition>100240 - Disclosure - Quarterly Results (unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100260 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureProductRevenueNetTables" id="Role_DisclosureProductRevenueNetTables">
        <link:definition>100270 - Disclosure - Product Revenue, Net (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsTables" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsTables">
        <link:definition>100280 - Disclosure - License, Collaboration and Other Significant Agreements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombinationTables" id="Role_DisclosureBusinessCombinationTables">
        <link:definition>100290 - Disclosure - Business Combination (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAvailableForSaleSecuritiesTables" id="Role_DisclosureAvailableForSaleSecuritiesTables">
        <link:definition>100300 - Disclosure - Available for Sale Securities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables" id="Role_DisclosureFairValueOfFinancialInstrumentsTables">
        <link:definition>100310 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureInventoryTables" id="Role_DisclosureInventoryTables">
        <link:definition>100320 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillTables" id="Role_DisclosureIntangibleAssetsAndGoodwillTables">
        <link:definition>100330 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAccruedExpensesTables" id="Role_DisclosureAccruedExpensesTables">
        <link:definition>100340 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>100350 - Disclosure - Stockholders&apos; Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100360 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100370 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100380 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureQuarterlyResultsUnauditedTables" id="Role_DisclosureQuarterlyResultsUnauditedTables">
        <link:definition>100390 - Disclosure - Quarterly Results (unaudited) (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureNatureOfOrganizationAndOperationsAdditionalInformationDetails" id="Role_DisclosureNatureOfOrganizationAndOperationsAdditionalInformationDetails">
        <link:definition>100400 - Disclosure - Nature of Organization and Operations - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100410 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesImpactOnConsolidatedStatementOfOperationsAndComprehensiveLossAsResultOfAdoptingASC606Details" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesImpactOnConsolidatedStatementOfOperationsAndComprehensiveLossAsResultOfAdoptingASC606Details">
        <link:definition>100420 - Disclosure - Summary of Significant Accounting Policies - Impact on Consolidated Statement of Operations and Comprehensive Loss as Result of Adopting ASC 606 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesImpactOnConsolidatedBalanceSheetsAsResultOfAdoptingASC606Details" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesImpactOnConsolidatedBalanceSheetsAsResultOfAdoptingASC606Details">
        <link:definition>100430 - Disclosure - Summary of Significant Accounting Policies - Impact on Consolidated Balance Sheets as Result of Adopting ASC 606 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesImpactOnConsolidatedStatementOfCashFlowsAsResultOfAdoptingASC606Details" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesImpactOnConsolidatedStatementOfCashFlowsAsResultOfAdoptingASC606Details">
        <link:definition>100440 - Disclosure - Summary of Significant Accounting Policies - Impact on Consolidated Statement of Cash Flows as Result of Adopting ASC 606 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesReconciliationOfCashCashEquivalentsAndRestrictedCashDetails">
        <link:definition>100450 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueAndGrossAccountsReceivableByMajorCustomerDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesRevenueAndGrossAccountsReceivableByMajorCustomerDetails">
        <link:definition>100460 - Disclosure - Summary of Significant Accounting Policies - Revenue and Gross Accounts Receivable By Major Customer (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAndRelatedAccumulatedDepreciationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAndRelatedAccumulatedDepreciationDetails">
        <link:definition>100470 - Disclosure - Summary of Significant Accounting Policies - Summary of Property and Equipment and Related Accumulated Depreciation (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureProductRevenueNetAdditionalInformationDetails" id="Role_DisclosureProductRevenueNetAdditionalInformationDetails">
        <link:definition>100480 - Disclosure - Product Revenue, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureProductRevenueNetSummaryOfProductRevenueAllowanceAndReserveCategoriesDetails" id="Role_DisclosureProductRevenueNetSummaryOfProductRevenueAllowanceAndReserveCategoriesDetails">
        <link:definition>100490 - Disclosure - Product Revenue, Net - Summary of Product Revenue Allowance and Reserve Categories (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsAdditionalInformationDetails" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - License, Collaboration and Other Significant Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsRevenuesRecognizedFromLicenseCollaborationAndOtherSignificantAgreementsDetails" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsRevenuesRecognizedFromLicenseCollaborationAndOtherSignificantAgreementsDetails">
        <link:definition>100510 - Disclosure - License, Collaboration and Other Significant Agreements - Revenues Recognized From License, Collaboration and Other Significant Agreements (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsDeferredRevenuesBalanceDetails" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsDeferredRevenuesBalanceDetails">
        <link:definition>100520 - Disclosure - License, Collaboration and Other Significant Agreements - Deferred Revenues Balance (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsScheduleOfChangesInContractAssetsAndLiabilitiesDetails" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsScheduleOfChangesInContractAssetsAndLiabilitiesDetails">
        <link:definition>100530 - Disclosure - License, Collaboration and Other Significant Agreements - Schedule of Changes In Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsScheduleOfChangesInContractAssetsAndLiabilitiesParentheticalDetails" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsScheduleOfChangesInContractAssetsAndLiabilitiesParentheticalDetails">
        <link:definition>100540 - Disclosure - License, Collaboration and Other Significant Agreements - Schedule of Changes In Contract Assets and Liabilities (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureLicenseCollaborationAndOtherSignificantAgreementsScheduleOfRevenueRecognizedResultingFromChangesInContractAssetAndContractLiabilityDetails" id="Role_DisclosureLicenseCollaborationAndOtherSignificantAgreementsScheduleOfRevenueRecognizedResultingFromChangesInContractAssetAndContractLiabilityDetails">
        <link:definition>100550 - Disclosure - License, Collaboration and Other Significant Agreements - Schedule of Revenue Recognized Resulting from Changes in Contract Asset and Contract Liability (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails" id="Role_DisclosureBusinessCombinationAdditionalInformationDetails">
        <link:definition>100560 - Disclosure - Business Combination - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombinationSummaryOfTotalFairValueConsiderationDetails" id="Role_DisclosureBusinessCombinationSummaryOfTotalFairValueConsiderationDetails">
        <link:definition>100570 - Disclosure - Business Combination - Summary of Total Fair Value Consideration (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombinationSummaryOfTotalFairValueConsiderationParentheticalDetails" id="Role_DisclosureBusinessCombinationSummaryOfTotalFairValueConsiderationParentheticalDetails">
        <link:definition>100580 - Disclosure - Business Combination - Summary of Total Fair Value Consideration (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombinationSummaryOfPurchasePriceOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" id="Role_DisclosureBusinessCombinationSummaryOfPurchasePriceOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>100590 - Disclosure - Business Combination - Summary of Purchase Price of Identifiable Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureBusinessCombinationSummaryOfUnauditedEstimatedProFormaFinancialInformationDetails" id="Role_DisclosureBusinessCombinationSummaryOfUnauditedEstimatedProFormaFinancialInformationDetails">
        <link:definition>100600 - Disclosure - Business Combination - Summary of Unaudited Estimated Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAvailableForSaleSecuritiesSummaryOfAvailableForSaleSecuritiesAtFairValueDetails" id="Role_DisclosureAvailableForSaleSecuritiesSummaryOfAvailableForSaleSecuritiesAtFairValueDetails">
        <link:definition>100610 - Disclosure - Available for Sale Securities - Summary of Available for Sale Securities at Fair Value (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAvailableForSaleSecuritiesEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetails" id="Role_DisclosureAvailableForSaleSecuritiesEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetails">
        <link:definition>100620 - Disclosure - Available for Sale Securities - Estimated Fair Value of Available for Sale Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAvailableForSaleSecuritiesAdditionalInformationDetails" id="Role_DisclosureAvailableForSaleSecuritiesAdditionalInformationDetails">
        <link:definition>100630 - Disclosure - Available for Sale Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAvailableForSaleSecuritiesSummaryOfAvailableForSaleSecuritiesThatWereInContinuousUnrealizedLossPositionDetails" id="Role_DisclosureAvailableForSaleSecuritiesSummaryOfAvailableForSaleSecuritiesThatWereInContinuousUnrealizedLossPositionDetails">
        <link:definition>100640 - Disclosure - Available for Sale Securities - Summary of Available for Sale Securities that were in Continuous Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAssetsMeasuredOrDisclosedAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueOfFinancialInstrumentsAssetsMeasuredOrDisclosedAtFairValueOnRecurringBasisDetails">
        <link:definition>100650 - Disclosure - Fair Value of Financial Instruments - Assets Measured or Disclosed at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" id="Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails">
        <link:definition>100660 - Disclosure - Fair Value of Financial Instruments - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureInventoryComponentsOfInventoryDetails" id="Role_DisclosureInventoryComponentsOfInventoryDetails">
        <link:definition>100670 - Disclosure - Inventory - Components of Inventory (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureInventoryComponentsOfInventoryDetails2" id="Role_DisclosureInventoryComponentsOfInventoryDetails2">
        <link:definition>100680 - Disclosure - Inventory - Components of Inventory (Details)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureInventoryAdditionalInformationDetails" id="Role_DisclosureInventoryAdditionalInformationDetails">
        <link:definition>100690 - Disclosure - Inventory - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillSummaryOfIntangibleAssetsDetails" id="Role_DisclosureIntangibleAssetsAndGoodwillSummaryOfIntangibleAssetsDetails">
        <link:definition>100700 - Disclosure - Intangible Assets and Goodwill - Summary of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformationDetails" id="Role_DisclosureIntangibleAssetsAndGoodwillAdditionalInformationDetails">
        <link:definition>100710 - Disclosure - Intangible Assets and Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillScheduleOfEstimatedFutureAmortizationExpenseForIntangibleAssetsDetails" id="Role_DisclosureIntangibleAssetsAndGoodwillScheduleOfEstimatedFutureAmortizationExpenseForIntangibleAssetsDetails">
        <link:definition>100720 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Future Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureAccruedExpensesComponentsOfAccruedExpensesDetails" id="Role_DisclosureAccruedExpensesComponentsOfAccruedExpensesDetails">
        <link:definition>100730 - Disclosure - Accrued Expenses - Components of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureDebtAdditionalInformationDetails" id="Role_DisclosureDebtAdditionalInformationDetails">
        <link:definition>100740 - Disclosure - Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureWarrantAdditionalInformationDetails" id="Role_DisclosureWarrantAdditionalInformationDetails">
        <link:definition>100750 - Disclosure - Warrant - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="Role_DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>100760 - Disclosure - Stockholders&apos; Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquitySummaryOfReservedSharesOfCommonStockForFutureIssuanceDetails" id="Role_DisclosureStockholdersEquitySummaryOfReservedSharesOfCommonStockForFutureIssuanceDetails">
        <link:definition>100770 - Disclosure - Stockholders&apos; Equity - Summary of Reserved Shares of Common Stock for Future Issuance (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquitySummaryOfReservedSharesOfCommonStockForFutureIssuanceParentheticalDetails" id="Role_DisclosureStockholdersEquitySummaryOfReservedSharesOfCommonStockForFutureIssuanceParentheticalDetails">
        <link:definition>100780 - Disclosure - Stockholders&apos; Equity - Summary of Reserved Shares of Common Stock for Future Issuance (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelDetails" id="Role_DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelDetails">
        <link:definition>100790 - Disclosure - Stockholders&apos; Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails" id="Role_DisclosureStockholdersEquityScheduleOfStockOptionActivityDetails">
        <link:definition>100800 - Disclosure - Stockholders&apos; Equity - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityScheduleOfPerformanceBasedOptionActivityDetails" id="Role_DisclosureStockholdersEquityScheduleOfPerformanceBasedOptionActivityDetails">
        <link:definition>100810 - Disclosure - Stockholders&apos; Equity - Schedule of Performance-based Option Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanyRestrictedStockActivityDetails" id="Role_DisclosureStockholdersEquitySummaryOfCompanyRestrictedStockActivityDetails">
        <link:definition>100820 - Disclosure - Stockholders&apos; Equity - Summary of Company Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityCompensationCostRelatedToShareBasedAwardsDetails" id="Role_DisclosureStockholdersEquityCompensationCostRelatedToShareBasedAwardsDetails">
        <link:definition>100830 - Disclosure - Stockholders Equity - Compensation Cost Related to Share-Based Awards (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompensationExpenseByTypeOfAwardDetails" id="Role_DisclosureStockholdersEquityScheduleOfCompensationExpenseByTypeOfAwardDetails">
        <link:definition>100840 - Disclosure - Stockholders Equity - Schedule of Compensation Expense by Type of Award (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100850 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" id="Role_DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
        <link:definition>100860 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateDiffersFromStatutoryFederalIncomeTaxRateDetails" id="Role_DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateDiffersFromStatutoryFederalIncomeTaxRateDetails">
        <link:definition>100870 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Differs From Statutory Federal Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantDeferredTaxAssetsAndLiabilitiesDetails" id="Role_DisclosureIncomeTaxesScheduleOfSignificantDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>100880 - Disclosure - Income Taxes -Schedule of Significant Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureEmployeeRetirementPlanAdditionalInformationDetails" id="Role_DisclosureEmployeeRetirementPlanAdditionalInformationDetails">
        <link:definition>100890 - Disclosure - Employee Retirement Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100900 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsRequiredUnderLeasesDetails" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsRequiredUnderLeasesDetails">
        <link:definition>100910 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Required Under Leases (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
        <link:definition>100920 - Disclosure - Net Loss per Share - Anti-Dilutive Securities Excluded from Calculation of Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://akebia.com/20181231/taxonomy/role/DisclosureQuarterlyResultsUnauditedDetails" id="Role_DisclosureQuarterlyResultsUnauditedDetails">
        <link:definition>100930 - Disclosure - Quarterly Results (unaudited) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </appinfo>
  </annotation>
  <element id="akba_InventoryGrossBeforeOtherInventory" name="InventoryGrossBeforeOtherInventory" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_DeferredTaxAssetsOtherNonCurrentLiabilities" name="DeferredTaxAssetsOtherNonCurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_AmortizationOfIntangibleAssetsProduct" name="AmortizationOfIntangibleAssetsProduct" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_LicenseExpense" name="LicenseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_LicenseCollaborationAndOtherRevenueMember" name="LicenseCollaborationAndOtherRevenueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_NoncashInterestExpense" name="NoncashInterestExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_FairValueWriteUpOfInventorySold" name="FairValueWriteUpOfInventorySold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_IncreaseDecreaseInDeferredRent" name="IncreaseDecreaseInDeferredRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_PaymentsToAcquireBusinessesNetOfAcquiredCashAndRestrictedCash" name="PaymentsToAcquireBusinessesNetOfAcquiredCashAndRestrictedCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" name="ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_DeferredFollowOnOfferingIssuanceCosts" name="DeferredFollowOnOfferingIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_WarrantDisclosureTextBlock" name="WarrantDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_WarrantDisclosureAbstract" name="WarrantDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" name="ReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ScheduleOfProductRevenueAllowanceAndReserveCategoriesTableTextBlock" name="ScheduleOfProductRevenueAllowanceAndReserveCategoriesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CollaborativeArrangementRevenueRecognitionTableTextBlock" name="CollaborativeArrangementRevenueRecognitionTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_DeferredRevenueRecognitionTableTextBlock" name="DeferredRevenueRecognitionTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ScheduleOfRevenueRecognizedResultingFromChangesInContractAssetAndContractLiabilityTableTextBlock" name="ScheduleOfRevenueRecognizedResultingFromChangesInContractAssetAndContractLiabilityTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ScheduleOfBusinessAcquisitionsTransactionPriceTextBlock" name="ScheduleOfBusinessAcquisitionsTransactionPriceTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CommonStockReservedForFutureIssuanceTableTextBlock" name="CommonStockReservedForFutureIssuanceTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByAwardTableTextBlock" name="ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByAwardTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_BusinessCombinationEquityCancelledAndConvertedNumberOfSharesIssued" name="BusinessCombinationEquityCancelledAndConvertedNumberOfSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_NatureOfOrganizationAndOperationsLineItems" name="NatureOfOrganizationAndOperationsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_NatureOfOrganizationAndOperationsTable" name="NatureOfOrganizationAndOperationsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_MergerAgreementMember" name="MergerAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_KeryxBiopharmaceuticalsIncMember" name="KeryxBiopharmaceuticalsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ProtectAndInnovateMember" name="ProtectAndInnovateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LargerInnovateMember" name="LargerInnovateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SmallerInnovateMember" name="SmallerInnovateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_MitsubishiTanabePharmaCorporationMember" name="MitsubishiTanabePharmaCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_CommercialMilestonePaymentsMember" name="CommercialMilestonePaymentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentAndCommercializeCollaborationAgreementMember" name="DevelopmentAndCommercializeCollaborationAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_PotentialDevelopmentAndCommercializationMilestonesMember" name="PotentialDevelopmentAndCommercializationMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_PotentialCommercialMilestonePaymentsMember" name="PotentialCommercialMilestonePaymentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_GlobalDevelopmentPlanMember" name="GlobalDevelopmentPlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_OtsukaPharmaceuticalCompanyLimitedMember" name="OtsukaPharmaceuticalCompanyLimitedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentAndCommercializeCollaborationAndLicenseAgreementMember" name="DevelopmentAndCommercializeCollaborationAndLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_FollowOnPublicOfferingMember" name="FollowOnPublicOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_CantorFitzgeraldAndCompanyMember" name="CantorFitzgeraldAndCompanyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ViforPharmaMember" name="ViforPharmaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_OtsukaPharmaceuticalCompanyLimitedAndMitsubishiTanabePharmaCorporationMember" name="OtsukaPharmaceuticalCompanyLimitedAndMitsubishiTanabePharmaCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LicenseAgreementMember" name="LicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_NumberOfPatients" name="NumberOfPatients" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_NumberOfEnrolledSubjects" name="NumberOfEnrolledSubjects" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_MilestonePaymentReceived" name="MilestonePaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_UpfrontCashPaymentReceived" name="UpfrontCashPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PotentialPaymentForAchievementOfSpecifiedCommercialMilestones" name="PotentialPaymentForAchievementOfSpecifiedCommercialMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PotentialPaymentForAchievementOfSpecifiedDevelopmentAndRegulatoryMilestones" name="PotentialPaymentForAchievementOfSpecifiedDevelopmentAndRegulatoryMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_RoyaltyPaymentPercentage" name="RoyaltyPaymentPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_CollaborativeArrangementsCostSharingPayments" name="CollaborativeArrangementsCostSharingPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_PaymentReceivedForLicenseAgreementReimbursementOfPreviouslyCostsIncurred" name="PaymentReceivedForLicenseAgreementReimbursementOfPreviouslyCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_MinimumCommittedAmountInCostShareFundingAndLicensePaymentsUnderCollaborationAgreements" name="MinimumCommittedAmountInCostShareFundingAndLicensePaymentsUnderCollaborationAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_OperatingPlanSufficientlyFundedByCashResourcesPeriod" name="OperatingPlanSufficientlyFundedByCashResourcesPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AllocatedArrangementConsiderationUnderLicenseAgreement" name="AllocatedArrangementConsiderationUnderLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentMilestonesPaymentMember" name="DevelopmentMilestonesPaymentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SalesAndCollaborationRevenueGrossMember" name="SalesAndCollaborationRevenueGrossMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_OtsukaUSAgreementMember" name="OtsukaUSAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_FreseniusMedicalCareRxMember" name="FreseniusMedicalCareRxMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_McKessonCorporationMember" name="McKessonCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_CardinalHealthIncMember" name="CardinalHealthIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_AmerisourceBergenDrugCorporationMember" name="AmerisourceBergenDrugCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ComputerEquipmentAndSoftwareMember" name="ComputerEquipmentAndSoftwareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_CostShareCostsIncurredForLicenseAgreement" name="CostShareCostsIncurredForLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_PaymentReceivedForLicenseAgreementReimbursementOfCostsIncurred" name="PaymentReceivedForLicenseAgreementReimbursementOfCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_CostShareCostsIncurredByPartnerForLicenseAgreement" name="CostShareCostsIncurredByPartnerForLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_PaymentForLicenseAgreementReimbursementOfCostsIncurred" name="PaymentForLicenseAgreementReimbursementOfCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_FairValueRemeasurementsToPropertyAndEquipment" name="FairValueRemeasurementsToPropertyAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_ChargebacksAndDiscountsMember" name="ChargebacksAndDiscountsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_RebatesFeesAndOtherDeductionsMember" name="RebatesFeesAndOtherDeductionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ReturnsMember" name="ReturnsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_MitsubishiTanabePharmaCorporationAndOtsukaPharmaceuticalCompanyLimitedMember" name="MitsubishiTanabePharmaCorporationAndOtsukaPharmaceuticalCompanyLimitedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_JapanTobaccoIncorporationAndToriiPharmaceuticalCompanyLimitedMember" name="JapanTobaccoIncorporationAndToriiPharmaceuticalCompanyLimitedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ClinicalAndRegulatoryActivitiesMember" name="ClinicalAndRegulatoryActivitiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_UpfrontPaymentMember" name="UpfrontPaymentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentAndRegulatoryMilestonesMember" name="DevelopmentAndRegulatoryMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentRegulatoryAndSalesMilestonesMember" name="DevelopmentRegulatoryAndSalesMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentRegulatoryAndCommercialEventsMilestonesPaymentMember" name="DevelopmentRegulatoryAndCommercialEventsMilestonesPaymentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_RegulatoryMilestonePaymentsMember" name="RegulatoryMilestonePaymentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_NewDevelopmentAndCommercializeCollaborationAgreementMember" name="NewDevelopmentAndCommercializeCollaborationAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentAndCommercializeResearchAndLicenseAgreementMember" name="DevelopmentAndCommercializeResearchAndLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentMilestonesPaymentOneMember" name="DevelopmentMilestonesPaymentOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentMilestonesPaymentTwoMember" name="DevelopmentMilestonesPaymentTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_UpFrontNonRefundableAndNonCreditableMember" name="UpFrontNonRefundableAndNonCreditableMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentAndCommercializeUnitedStatesCollaborationAndLicenseAgreementMember" name="DevelopmentAndCommercializeUnitedStatesCollaborationAndLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopmentAndCommercializeInternationalCollaborationAndLicenseAgreementMember" name="DevelopmentAndCommercializeInternationalCollaborationAndLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_JanssenPharmaceuticaNVMember" name="JanssenPharmaceuticaNVMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_JohnsonAndJohnsonInnovationMember" name="JohnsonAndJohnsonInnovationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ViforInternationalLimitedMember" name="ViforInternationalLimitedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_PanionAndBFBiotechIncorporationMember" name="PanionAndBFBiotechIncorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SublicenseAgreementMember" name="SublicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LicenseCollaborationAndOtherRevenueAbstract" name="LicenseCollaborationAndOtherRevenueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ContractWithCustomerAssetAdditions" name="ContractWithCustomerAssetAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_ContractWithCustomerAssetDeductions" name="ContractWithCustomerAssetDeductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_DeferredRevenueMember" name="DeferredRevenueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ContractWithCustomerLiabilityAdditions" name="ContractWithCustomerLiabilityAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_ContractWithCustomerLiabilityDeductions" name="ContractWithCustomerLiabilityDeductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_PotentialPaymentForAchievementOfSpecifiedMilestones" name="PotentialPaymentForAchievementOfSpecifiedMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PercentageOfRoyaltyPaymentsOnSales" name="PercentageOfRoyaltyPaymentsOnSales" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_IncurredClinicalAndCommercialDevelopmentCost" name="IncurredClinicalAndCommercialDevelopmentCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_ProceedsFromReimbursementOfDevelopmentCostsIncurred" name="ProceedsFromReimbursementOfDevelopmentCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_DevelopmentCostsIncurred" name="DevelopmentCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_CollaborationAgreementExpirationPeriod" name="CollaborationAgreementExpirationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CollaborationAgreementTerminationNoticePeriod" name="CollaborationAgreementTerminationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AdditionalMilestoneOrRoyaltyPaymentsReceived" name="AdditionalMilestoneOrRoyaltyPaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_DataAccessFeeReceivable" name="DataAccessFeeReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_NumberOfPerformanceObligations" name="NumberOfPerformanceObligations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CostOfResearchServices" name="CostOfResearchServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PercentageOfIncreaseInFundingToFundCurrentGlobalDevelopmentCosts" name="PercentageOfIncreaseInFundingToFundCurrentGlobalDevelopmentCosts" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ReductionInPercentageOfFuturePaymentsDueUponCurrentGlobalDevelopmentCostsCreditable" name="ReductionInPercentageOfFuturePaymentsDueUponCurrentGlobalDevelopmentCostsCreditable" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_PercentageOfRemainingCreditableAmountAppliedToFuturePayments" name="PercentageOfRemainingCreditableAmountAppliedToFuturePayments" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_PotentialPaymentForAchievementOfSpecifiedDevelopmentMilestones" name="PotentialPaymentForAchievementOfSpecifiedDevelopmentMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PotentialPaymentForAchievementOfSpecifiedRegulatoryMilestones" name="PotentialPaymentForAchievementOfSpecifiedRegulatoryMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_ThresholdForPercentageOfMarketPenetrationForLicenseAgreementExpiration" name="ThresholdForPercentageOfMarketPenetrationForLicenseAgreementExpiration" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_LicenseAgreementTerminationNoticePeriod" name="LicenseAgreementTerminationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CollaborativeAndLicenseArrangementTransactionPrice" name="CollaborativeAndLicenseArrangementTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PaymentReceivableForLicenseAgreementReimbursementOfPreviouslyCostsIncurred" name="PaymentReceivableForLicenseAgreementReimbursementOfPreviouslyCostsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_EstimateSubsequentCostFundingUnderPlan" name="EstimateSubsequentCostFundingUnderPlan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_MilestoneOrRoyaltyPaymentReceived" name="MilestoneOrRoyaltyPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_UpfrontPaymentPaidInCash" name="UpfrontPaymentPaidInCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_ClosingStockPriceOfCommonStock" name="ClosingStockPriceOfCommonStock" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_CollaborativeArrangementOfPremiumAmountOverClosingStockPriceOfCommonStock" name="CollaborativeArrangementOfPremiumAmountOverClosingStockPriceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_LicenseAgreementPayment" name="LicenseAgreementPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_RoyaltyPaymentsDueToRelatedParty" name="RoyaltyPaymentsDueToRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PotentialPaymentForAchievementOfAnnualNetSalesMilestones" name="PotentialPaymentForAchievementOfAnnualNetSalesMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_PriorWrittenNoticeForTerminationOnBreachOfAgreementPeriod" name="PriorWrittenNoticeForTerminationOnBreachOfAgreementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_NotesConversionAgreementMember" name="NotesConversionAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_AuryxiaMember" name="AuryxiaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_NonRecurringChargesMember" name="NonRecurringChargesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_PrecombinationEmployeeServicesMember" name="PrecombinationEmployeeServicesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfAdditionalSharesExpectedToBeIssuedForAllTransactions" name="SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfAdditionalSharesExpectedToBeIssuedForAllTransactions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AggregateNumberOfSharesAvailableForConversion" name="AggregateNumberOfSharesAvailableForConversion" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_FairValueOfSubsidiaryOrEquityMethodInvesteeCumulativeNumberOfAdditionalSharesIssuedForAllTransactions" name="FairValueOfSubsidiaryOrEquityMethodInvesteeCumulativeNumberOfAdditionalSharesIssuedForAllTransactions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherIntangibleAssets" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesFairValueOfOffMarketElement" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesFairValueOfOffMarketElement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_BusinessCombinationRiskAdjustedDiscountRatesUsedToCalculatePresentValueOfFutureExpectedCashInflowsOfIntangibleAssets" name="BusinessCombinationRiskAdjustedDiscountRatesUsedToCalculatePresentValueOfFutureExpectedCashInflowsOfIntangibleAssets" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_BusinessCombinationStockBasedCompensationExpenses" name="BusinessCombinationStockBasedCompensationExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_BusinessCombinationBonusAndSeverancePayments" name="BusinessCombinationBonusAndSeverancePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_BusinessCombinationTaxBenefits" name="BusinessCombinationTaxBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" name="BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" name="CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_AvailableForSaleSecuritiesDebtSecuritiesCurrentIncludingCashAndCashEquivalents" name="AvailableForSaleSecuritiesDebtSecuritiesCurrentIncludingCashAndCashEquivalents" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_CertificatesOfDepositAvailableForSaleSecuritiesMember" name="CertificatesOfDepositAvailableForSaleSecuritiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_DevelopedProductRightsForAuryxiaMember" name="DevelopedProductRightsForAuryxiaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_AccruedClinicalExpensesCurrent" name="AccruedClinicalExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_AccruedProductRevenueAllowancesCurrent" name="AccruedProductRevenueAllowancesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_AccruedMergerCostsCurrent" name="AccruedMergerCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_AccruedCommercialManufacturingCurrent" name="AccruedCommercialManufacturingCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_LoanAndSecurityAgreementMember" name="LoanAndSecurityAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SiliconValleyBankMember" name="SiliconValleyBankMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LineOfCreditTerminationFeePercentage" name="LineOfCreditTerminationFeePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_MinimumLiquidityRatio" name="MinimumLiquidityRatio" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_DebtDefaultLineOfCreditPercentage" name="DebtDefaultLineOfCreditPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ClassOfWarrantOrRightExpirationDate" name="ClassOfWarrantOrRightExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_JanssenAgreementMember" name="JanssenAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_AtTheMarketEquityOfferingProgramMember" name="AtTheMarketEquityOfferingProgramMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ServiceBasedStockOptionsMember" name="ServiceBasedStockOptionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_PerformanceBasedStockOptionsMember" name="PerformanceBasedStockOptionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ServiceBasedRestrictedStockUnitsMember" name="ServiceBasedRestrictedStockUnitsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_InducementAwardProgramMember" name="InducementAwardProgramMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_TwoThousandAndFourteenPlansMember" name="TwoThousandAndFourteenPlansMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_EmployeesMember" name="EmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" name="TwoThousandAndFourteenEmployeeStockPurchasePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ShareBasedCompensationAwardTrancheFirstAnniversaryOfGrantDateMember" name="ShareBasedCompensationAwardTrancheFirstAnniversaryOfGrantDateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_NonEmployeesMember" name="NonEmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_StockOptionsAndRestrictedStockUnitsMember" name="StockOptionsAndRestrictedStockUnitsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_CommonStockSalesAgreementAmount" name="CommonStockSalesAgreementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardConvertedOutstandingAndUnexercisedOptionsToPurchase" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardConvertedOutstandingAndUnexercisedOptionsToPurchase" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedOutstandingOptions" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedOutstandingOptions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AnnualIncreaseInAggregateNumberOfSharesReservedForFutureIssuanceAsPercentageSharesOutstanding" name="AnnualIncreaseInAggregateNumberOfSharesReservedForFutureIssuanceAsPercentageSharesOutstanding" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInAcquiredShares" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInAcquiredShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInMerger" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInMerger" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentageOfCommonStockIssued" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentageOfCommonStockIssued" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesOfOutstandingStock" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesOfOutstandingStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_EmployeeStockOptionAndRestrictedStockUnitsRSUMember" name="EmployeeStockOptionAndRestrictedStockUnitsRSUMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_IncreaseDecreaseInCommonStockCapitalSharesReservedForFutureIssuance" name="IncreaseDecreaseInCommonStockCapitalSharesReservedForFutureIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesAvailableForPurchase" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesAvailableForPurchase" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_AllocatedShareBasedCompensationGrantedExpense" name="AllocatedShareBasedCompensationGrantedExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodicVestingNumberOfInstallments" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodicVestingNumberOfInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInConnectionWithAcquiredShares" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInConnectionWithAcquiredShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInConnectionWithMergerWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInConnectionWithMergerWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" name="ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialShareIssuablePercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPotentialShareIssuablePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsUponAchievementOfPerformanceConditionPercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsUponAchievementOfPerformanceConditionPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsFollowingAchievementOfPerformanceConditionPercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsFollowingAchievementOfPerformanceConditionPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInMerger" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInMerger" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInMergerWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInMergerWeightedAverageGrantDateFairValue" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_FederalAndStateMember" name="FederalAndStateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_EffectiveIncomeTaxReconciliationAlternativeMinimumTax" name="EffectiveIncomeTaxReconciliationAlternativeMinimumTax" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_EffectiveIncomeTaxRateReconciliationIncreaseDecreaseInDeferredTaxAssetsDueToChangeInOwnership" name="EffectiveIncomeTaxRateReconciliationIncreaseDecreaseInDeferredTaxAssetsDueToChangeInOwnership" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_TaxCutsAndJobsActOf2017ChangeInTaxRateReductionInDeferredTaxAsset" name="TaxCutsAndJobsActOf2017ChangeInTaxRateReductionInDeferredTaxAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_AlternativeMinimumTaxPayable" name="AlternativeMinimumTaxPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_AlternativeMinimumTaxReceivable" name="AlternativeMinimumTaxReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_DeferredIncomeTaxAmortization" name="DeferredIncomeTaxAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_TaxCutsAndJobsActOf2017OperatingLossCarryForwardsIndefinitely" name="TaxCutsAndJobsActOf2017OperatingLossCarryForwardsIndefinitely" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_TermOfChangeInOwnershipOfStockholders" name="TermOfChangeInOwnershipOfStockholders" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_PercentageOfChangeInOwnershipOfStockholders" name="PercentageOfChangeInOwnershipOfStockholders" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_PercentageOfChangeInOwnershipOfStockholdersHoldingOutstandingStock" name="PercentageOfChangeInOwnershipOfStockholdersHoldingOutstandingStock" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_IncreaseDecreaseInDeferredTaxAssets" name="IncreaseDecreaseInDeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_LiabilityForUncertainTaxPositions" name="LiabilityForUncertainTaxPositions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_DefinedContributionPlanEmployeesAgeToBeEligibleUnderPlan" name="DefinedContributionPlanEmployeesAgeToBeEligibleUnderPlan" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_OperatingLeasePaymentsCommencementDate" name="OperatingLeasePaymentsCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_LeasedPropertyDeliveredDate" name="LeasedPropertyDeliveredDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_LeasedPropertySubjectToAnnualRentEscalationsCommencementDate" name="LeasedPropertySubjectToAnnualRentEscalationsCommencementDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LeaseAmendmentMember" name="LeaseAmendmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_ThirdAmendmentToCambridgeLeaseMember" name="ThirdAmendmentToCambridgeLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LeaseMonthlyPaymentsOnOrAboutJanuary12017Member" name="LeaseMonthlyPaymentsOnOrAboutJanuary12017Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_FifthAmendmentToCambridgeLeaseMember" name="FifthAmendmentToCambridgeLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_OfficeSpaceMember" name="OfficeSpaceMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_BostonLeaseMember" name="BostonLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LabSpaceMember" name="LabSpaceMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_BioVectraIncMember" name="BioVectraIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_SiegfriedEvionnazSAMember" name="SiegfriedEvionnazSAMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_LeaseExpirationMonthYear" name="LeaseExpirationMonthYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_LesseeLeasingArrangementsOperatingLeasesNumberOfLeasePeriodExtensionOptions" name="LesseeLeasingArrangementsOperatingLeasesNumberOfLeasePeriodExtensionOptions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="akba_LeaseholdImprovementAllowanceNotYetUsed" name="LeaseholdImprovementAllowanceNotYetUsed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_CostOfPurchasedMinimumQuantityProduct" name="CostOfPurchasedMinimumQuantityProduct" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="akba_DescriptionOfTerminationOfAgreementPriorToContractTerm" name="DescriptionOfTerminationOfAgreementPriorToContractTerm" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AgreementExpirationYear" name="AgreementExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AgreementRenewalTermTermination" name="AgreementRenewalTermTermination" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AgreementEarlyTermination" name="AgreementEarlyTermination" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_AgreementExpirationDate" name="AgreementExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="akba_PurchaseCommittedProgramRemainingContractCosts" name="PurchaseCommittedProgramRemainingContractCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="akba_QuarterlyFinancialInformationLineItems" name="QuarterlyFinancialInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="akba_QuarterlyFinancialInformationTable" name="QuarterlyFinancialInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
</schema>




